SCHEMBL20050100

SCHEMBL20050100

C=C(C)Nc1ncc(-c2cc(C)ccc2N)cc1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.32
RAB9A P51151 2/20 0.32
NPC1 O15118 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TDP1 Q9NUW8 3/20 0.32
CYP3A4 P08684 2/20 0.32
TP53 P04637 1/20 0.32
THRB P10828 1/20 0.32
ALOX15 P16050 1/20 0.32
KDR P35968 4/20 0.31
PDGFRB P09619 3/20 0.31
ALDH1A1 P00352 3/20 0.31
TSHR P16473 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25588074 0.80 CHRNA7 (0.38) GRM5SMN1; SMN2RAB9ANPC1KDM4E
SCHEMBL20049992 0.78 CNR1 (0.39) RAB9ANPC1CYP1A2CYP2C19L3MBTL1
SCHEMBL20049830 0.77 EGLN1 (0.41) MAP4K4
SCHEMBL25588429 0.76 GRIN1 (0.35) NPC1ALDH1A1FYNMAP4K4
SCHEMBL20049904 0.76 GRIN2B (0.42) RAB9ANPC1ALDH1A1ABL1
SCHEMBL20049886 0.75 PSMB5 (0.42) GRM5RAB9ANPC1KDM4EKDR
SCHEMBL20049825 0.73 GSK3B (0.42) NPC1ALDH1A1MAPTMAP4K4
SCHEMBL20050027 0.73 GRIN2B (0.44)
SCHEMBL20049775 0.72 NPC1 (0.42) RAB9ANPC1KDRPDGFRBALDH1A1
SCHEMBL20049908 0.72 CYP1A2 (0.40) SMN1; SMN2RAB9ANPC1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067786-A1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-12 WO disclosed